Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Astellas Pharma Inc. ALPMF

Full chart Compare
Set alert

Price alert · ALPMF

All alert types
16.00 USD -1.40 (-8.05%)

At closeNov 6, 2026, 4:00 PM EST

16.00 Day range 16.00
11.00 52-week range 17.60
YTD
+21.49%
1 year
+45.45%

Financial health

Altman Z-Score

3.43 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A+4 / 5 overall

  • DCF 5
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 3
  • P/B 3

Valuation

P/E 15.6×
FY 2017: 14.3×FY 2018: 19.9×FY 2019: 15.0×FY 2020: 16.4×FY 2021: 26.4×FY 2022: 28.1×FY 2023: 34.9×FY 2024: 178×FY 2025: 51.6×FY 2026: 15.6×
FY 2017 5y median 34.9× FY 2026
P/S 2.1×
FY 2017: 2.4×FY 2018: 2.5×FY 2019: 2.6×FY 2020: 2.5×FY 2021: 2.5×FY 2022: 2.7×FY 2023: 2.3×FY 2024: 1.9×FY 2025: 1.4×FY 2026: 2.1×
FY 2017 5y median 2.1× FY 2026
P/B 2.5×
FY 2017: 2.5×FY 2018: 2.6×FY 2019: 2.7×FY 2020: 2.5×FY 2021: 2.3×FY 2022: 2.4×FY 2023: 2.3×FY 2024: 1.9×FY 2025: 1.7×FY 2026: 2.5×
FY 2017 5y median 2.3× FY 2026
P/FCF 9.0×
FY 2017: 16.7×FY 2018: 12.0×FY 2019: 16.2×FY 2020: 22.3×FY 2021: 13.9×FY 2022: 19.3×FY 2023: 14.4×FY 2024: 33.8×FY 2025: 19.2×FY 2026: 9.0×
FY 2017 5y median 19.2× FY 2026
EV/EBITDA 7.9×
FY 2017: 8.3×FY 2018: 8.8×FY 2019: 9.7×FY 2020: 10.5×FY 2021: 9.7×FY 2022: 11.4×FY 2023: 9.7×FY 2024: 19.0×FY 2025: 13.2×FY 2026: 7.9×
FY 2017 5y median 11.4× FY 2026
EV/Sales 2.3×
FY 2017: 2.1×FY 2018: 2.3×FY 2019: 2.3×FY 2020: 2.5×FY 2021: 2.5×FY 2022: 2.6×FY 2023: 2.2×FY 2024: 2.3×FY 2025: 1.7×FY 2026: 2.3×
FY 2017 5y median 2.3× FY 2026
FCF Yield 11.1%
FY 2017: 6.0%FY 2018: 8.3%FY 2019: 6.2%FY 2020: 4.5%FY 2021: 7.2%FY 2022: 5.2%FY 2023: 6.9%FY 2024: 3.0%FY 2025: 5.2%FY 2026: 11.1%
FY 2017 5y median 5.2% FY 2026

Profitability

Gross Margin 74.6%
FY 2017: 75.6%FY 2018: 77.4%FY 2019: 77.6%FY 2020: 78.7%FY 2021: 80.3%FY 2022: 80.5%FY 2023: 81.0%FY 2024: 81.8%FY 2025: 81.7%FY 2026: 74.6%
FY 2017 5y median 81.0% FY 2026
Operating Margin 19.6%
FY 2017: 19.9%FY 2018: 16.4%FY 2019: 18.7%FY 2020: 18.8%FY 2021: 10.9%FY 2022: 17.0%FY 2023: 8.8%FY 2024: 1.6%FY 2025: 2.1%FY 2026: 19.6%
FY 2017 5y median 8.8% FY 2026
Net Margin 13.6%
FY 2017: 16.7%FY 2018: 12.7%FY 2019: 17.0%FY 2020: 15.0%FY 2021: 9.7%FY 2022: 9.6%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 2.7%FY 2026: 13.6%
FY 2017 5y median 6.5% FY 2026
ROE 15.9%
FY 2017: 17.2%FY 2018: 13.0%FY 2019: 17.7%FY 2020: 15.2%FY 2021: 8.7%FY 2022: 8.5%FY 2023: 6.5%FY 2024: 1.1%FY 2025: 3.4%FY 2026: 15.9%
FY 2017 5y median 6.5% FY 2026
ROIC 12.5%
FY 2017: 14.2%FY 2018: 11.2%FY 2019: 15.6%FY 2020: 10.4%FY 2021: 6.2%FY 2022: 9.7%FY 2023: 5.5%FY 2024: 0.6%FY 2025: 1.6%FY 2026: 12.5%
FY 2017 5y median 5.5% FY 2026
ROA 8.2%
FY 2017: 12.0%FY 2018: 8.9%FY 2019: 11.7%FY 2020: 8.4%FY 2021: 5.3%FY 2022: 5.3%FY 2023: 4.0%FY 2024: 0.5%FY 2025: 1.5%FY 2026: 8.2%
FY 2017 5y median 4.0% FY 2026

Growth (YoY)

Revenue 12.6%
FY 2017: -4.4%FY 2018: -0.9%FY 2019: 0.5%FY 2020: -0.4%FY 2021: -3.9%FY 2022: 3.7%FY 2023: 17.2%FY 2024: 5.6%FY 2025: 19.2%FY 2026: 12.6%
FY 2017 FY 2026
Operating Income 929.1%
FY 2017: 4.8%FY 2018: -18.2%FY 2019: 14.4%FY 2020: 0.0%FY 2021: -44.2%FY 2022: 61.7%FY 2023: -39.5%FY 2024: -80.8%FY 2025: 60.8%FY 2026: 929.1%
FY 2017 FY 2026
EPS (diluted) 477.1%
FY 2017: 15.5%FY 2018: -21.8%FY 2019: 41.9%FY 2020: -9.4%FY 2021: -37.6%FY 2022: 3.3%FY 2023: -19.3%FY 2024: -82.5%FY 2025: 198.2%FY 2026: 477.1%
FY 2017 FY 2026
Free Cash Flow 273.0%
FY 2017: -4.4%FY 2018: 45.7%FY 2019: -24.2%FY 2020: -30.2%FY 2021: 59.2%FY 2022: -21.1%FY 2023: 32.2%FY 2024: -62.4%FY 2025: 52.5%FY 2026: 273.0%
FY 2017 FY 2026

Financial Health

Current Ratio 1.2×
FY 2017: 2.2×FY 2018: 2.0×FY 2019: 1.7×FY 2020: 1.1×FY 2021: 1.5×FY 2022: 1.3×FY 2023: 1.4×FY 2024: 0.9×FY 2025: 1.1×FY 2026: 1.2×
FY 2017 5y median 1.2× FY 2026
Quick Ratio 0.9×
FY 2017: 1.7×FY 2018: 1.7×FY 2019: 1.4×FY 2020: 0.9×FY 2021: 1.2×FY 2022: 1.1×FY 2023: 1.2×FY 2024: 0.7×FY 2025: 0.9×FY 2026: 0.9×
FY 2017 5y median 0.9× FY 2026
Debt / Equity 0.3×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.3×FY 2021: 0.2×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.6×FY 2025: 0.5×FY 2026: 0.3×
FY 2017 5y median 0.3× FY 2026
Net Debt / EBITDA 0.5×
FY 2017: -1.0×FY 2018: -1.0×FY 2019: -1.0×FY 2020: 0.3×FY 2021: -0.1×FY 2022: -0.3×FY 2023: -0.5×FY 2024: 3.4×FY 2025: 2.6×FY 2026: 0.5×
FY 2017 5y median 0.5× FY 2026
Interest Coverage 29.8×
FY 2017: 132×FY 2018: 120×FY 2019: 187×FY 2020: 81.2×FY 2021: 58.3×FY 2022: 44.5×FY 2023: 15.2×FY 2024: 2.1×FY 2025: 2.3×FY 2026: 29.8×
FY 2017 5y median 15.2× FY 2026

Dividends

Dividend Yield 3.0%
FY 2017: 2.2%FY 2018: 2.2%FY 2019: 2.2%FY 2020: 2.3%FY 2021: 2.4%FY 2022: 2.4%FY 2023: 2.9%FY 2024: 3.8%FY 2025: 4.9%FY 2026: 3.0%
FY 2017 5y median 3.0% FY 2026
Payout Ratio 46.7%
FY 2017: 32.1%FY 2018: 43.5%FY 2019: 32.4%FY 2020: 37.6%FY 2021: 63.2%FY 2022: 68.7%FY 2023: 101.7%FY 2024: 684.4%FY 2025: 254.2%FY 2026: 46.7%
FY 2017 5y median 101.7% FY 2026

Annual · latest fiscal year ends 2026-03-31